Market Place
Sourcing Support
Electra Presents Positive Phase 1b Results in sHLH at ASH 2024
09 Dec 2024 //
BUSINESSWIRE
Electra Therapeutics Presents ELA026 Results in sHLH at ASH 2024
05 Nov 2024 //
BUSINESSWIRE
Electra Gets FDA Orphan Drug Designation for ELA026 in HLH
30 Oct 2024 //
BUSINESSWIRE
Electra`s ELA026 Data In Late-Breaker At EHA 2024
03 Jun 2024 //
BUSINESSWIRE
Electra Appoints Graham Parry CSO, Kim-Hien Dao CMO
03 Jun 2024 //
BUSINESSWIRE
Electra Appoints Kathy Dong as President and Chief Executive Officer
11 Dec 2023 //
BUSINESSWIRE
Electra picks commercially-minded Kathy Dong as next CEO
11 Dec 2023 //
FIERCE BIOTECH
Electra Therapeutics to Present Clinical Data for ELA026 at ASH
02 Nov 2023 //
BUSINESSWIRE
Electra Therapeutics highlights ELA026 Phase 1b study in sHLH at ASH
12 Dec 2022 //
BUSINESSWIRE
Electra Therapeutics to Highlight ELA026 in Three Presentations at ASH
03 Nov 2022 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.